Topical Retinaldehyde on Human Skin: Biologic Effects and Tolerance
- 1 December 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 103 (6) , 770-774
- https://doi.org/10.1111/1523-1747.ep12412861
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Retinoic acid in psoriasis: its value for topical therapy with and without corticosteroidsBritish Journal of Dermatology, 2006
- Topical glucocorticosteroids modulate the expression of CRABP I and II in human skin differentlyExperimental Dermatology, 1994
- Cellular retinoic acid-binding proteins (CRABP)Experimental Dermatology, 1993
- Comparison of CD271 (Adapalene) and All-Trans Retinoic Acid in Human Skin: Dissociation of Epidermal Effects and CRABP-II mRNA ExpressionJournal of Investigative Dermatology, 1993
- Stimulus-Selective Induction of CRABP-II mRNA: A Marker for Retinoic Acid Action in Human SkinJournal of Investigative Dermatology, 1993
- Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro.Journal of Clinical Investigation, 1992
- Acute or Chronic Topical Retinoic Acid Treatment of Human Skin In Vivo Alters the Expression of Epidermal Transglutaminase, Loricrin, Involucrin, Filaggrin, and Keratins 6 and 13 but not Keratins 1, 10, and 14Journal of Investigative Dermatology, 1992
- Overexpression of Cellular Retinoic Acid-Binding Protein Type II (CRABP-II) and Down-Regulation of CRABP-I in Psoriatic SkinDermatology, 1992
- Cellular retinoic acid-binding protein type 2 mRNA is overexpressed in human psoriatic skin as shown by in situ hybridizationBiochemical and Biophysical Research Communications, 1991
- Ligand‐specific and non‐specific in vivo modulation of human epidermal cellular retinoic acid binding protein (CRABP)European Journal of Clinical Investigation, 1989